Biohit Oyj (BIOBV) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

EUR 43 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.37

Return on Equity

-27.48%

Price to Book

3.30

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Dec 2015)

Net Profit:

-2 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

30.15%

6 Months

28.73%

1 Year

54.59%

2 Years

84.38%

3 Years

102.29%

4 Years

83.42%

5 Years

77.0%

Biohit Oyj for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-31.57%

EBIT Growth (5y)

-229.91%

EBIT to Interest (avg)

-3.47

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.53

Sales to Capital Employed (avg)

0.65

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

0.96%

ROE (avg)

0.52%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.86

EV to EBIT

-7.58

EV to EBITDA

-7.58

EV to Capital Employed

3.97

EV to Sales

5.43

PEG Ratio

Dividend Yield

ROCE (Latest)

-52.44%

ROE (Latest)

-27.48%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'15 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2015 is 9.09% vs 37.50% in Dec 2014",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2015 is -25.00% vs 25.00% in Dec 2014",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'15",
        "Dec'14",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.20",
          "val2": "1.10",
          "chgp": "9.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.30",
          "val2": "-1.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.50",
          "val2": "-1.20",
          "chgp": "-25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,083.30%",
          "val2": "-1,181.80%",
          "chgp": "9.85%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 9.16% vs 19.09% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 36.84% vs 216.67% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14.30",
          "val2": "13.10",
          "chgp": "9.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.80",
          "val2": "2.20",
          "chgp": "27.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.10",
          "chgp": "200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.60",
          "val2": "1.90",
          "chgp": "36.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "173.50%",
          "val2": "140.90%",
          "chgp": "3.26%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'15 - YoY

Dec'15

Dec'14

Change(%)

Net Sales

1.20

1.10

9.09%

Operating Profit (PBDIT) excl Other Income

-1.30

Interest

0.10

0.00

Exceptional Items

0.00

Consolidate Net Profit

-1.50

-1.20

-25.00%

Operating Profit Margin (Excl OI)

-1,083.30%

-1,181.80%

9.85%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2015 is 9.09% vs 37.50% in Dec 2014

Consolidated Net Profit

YoY Growth in quarter ended Dec 2015 is -25.00% vs 25.00% in Dec 2014

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

14.30

13.10

9.16%

Operating Profit (PBDIT) excl Other Income

2.80

2.20

27.27%

Interest

0.30

0.10

200.00%

Exceptional Items

0.00

0.10

-100.00%

Consolidate Net Profit

2.60

1.90

36.84%

Operating Profit Margin (Excl OI)

173.50%

140.90%

3.26%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 9.16% vs 19.09% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 36.84% vs 216.67% in Dec 2023

All Annual Results

Company CV

About Biohit Oyj

Biohit Oyj

Pharmaceuticals & Biotechnology

Biohit Oyj is a Finland-based company engaged in the development, manufacture and marketing of diagnostic tests and analysis systems. The Company operates one business segment, named Diagnostics. The Diagnostics segment offers solutions for the early diagnosis and prevention of gastrointestinal diseases. It provides blood-sample examination based on GastroPanel for the diagnosis of stomach illnesses and associated risks, quick tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, as well as the ColonView examination for the early detection of fecal occult intestinal bleeding, which indicates a risk of colorectal cancer. The Company’s products are used in hospitals, healthcare centers and research institutions. It operates primarily in Europe and Asia. Furthermore, the Company is a parent of Biohit Healthcare Ltd, Biohit Healthcare Srl, Oy Finio Ab, and Vantaan Hienomekano Oy, among others.

Company Coordinates

Company Details

Laippatie 1 , HELSINKI None : 00880

Tel: 358 9 773861

http://www.biohithealthcare.com/

Registrar Details